Activated CD8+ T cells have an antitumor immune effect in a variety of tumors, and when PD-1 is combined with PD-L1, the activation, expansion, and effector function of CD8+ T cells can be inhibited so as to help tumor cells escape immune destruction, thus promoting tumor survival [346]. Here, CD274 is linked to neoplasm.